Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May;67(5):450-5.
doi: 10.1136/thoraxjnl-2012-201876.

Key observations from the NHLBI Asthma Clinical Research Network

Stanley J Szefler  1 , Vernon M Chinchilli, Elliot Israel, Loren Clark Denlinger, Robert F Lemanske Jr, William Calhoun, Stephen P Peters; National Heart, Lung and Blood Institute Asthma Clinical Research Network
Collaborators, Affiliations
Review

Key observations from the NHLBI Asthma Clinical Research Network

Stanley J Szefler et al. Thorax. 2012 May.

Abstract

The National Heart, Lung and Blood Institute (NHLBI) Asthma Clinical Research Network (ACRN) recently completed its work after 20 years of collaboration as a multicentre clinical trial network. When formed, its stated mission was to perform multiple controlled clinical trials for treating patients with asthma by dispassionately examining new and existing therapies, and to rapidly communicate its findings to the medical community. The ACRN conducted 15 major clinical trials. In addition, clinical data, manual of operations, protocols and template informed consents from all ACRN trials are available via NHLBI BioLINCC (https://biolincc.nhlbi.nih.gov/studies/). This network contributed major insights into the use of inhaled corticosteroids, short-acting and long-acting ß-adrenergic agonists, leukotriene receptor antagonists, and novel agents (tiotropium, colchicine and macrolide antibiotics). They also pioneered studies of the variability in drug response, predictors of treatment response and pharmacogenetics. This review highlights the major research observations from the ACRN that have impacted the current management of asthma.

PubMed Disclaimer

References

    1. Drazen JM, Israel E, Boushey HA, et al. for the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N Engl J Med. 1996;335:841–47. - PubMed
    1. Fish JE, Peters SP, Chambers CV, et al. for the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network An evaluation of colchicine as an alternative to inhaled corticosteroids in moderate asthma. Am J Respir Crit Care Med. 1997;156:1165–71. - PubMed
    1. Lazarus S, Boushey H, Fahy J, et al. for the Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute Long-acting β2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA. 2001;285:2583–93. - PubMed
    1. Lemanske RF, Jr, Sorkness C, Mauger EA, et al. for the Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA. 2001;285:2594–2603. - PubMed
    1. Martin RJ, Szefler SJ, Chinchilli VM, et al. for the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med. 2002;165:1377–83. - PubMed

Publication types

MeSH terms